close icon

Illumina Stock Outperforms, Walks on Thin Ice

There is no question that keeping all eggs in one basket is a risky strategy to rely on in the markets. However, if investors held nothing but Illumina stock for the last two years, they would have beaten the S&P 500 by a large margin. Shares in the biotechnology company have risen by over 76% since February, 2016, versus “only” 48.5% for the benchmark index.

But it was not at all clear that ILMN was poised for a rally back then. The stock had just crashed from an all-time high of $242 to as low as $130 in six months, following a five-wave impulse pattern we warned you about in “Illumina Not as Healthy as It Seems”, published in March, 2015. Almost a year later, in February 2016, with Illumina stock already down by 46%, the Elliott Wave Principle suggested it was time for the bulls to show up again.

illumina elliott wave analysis february 2016

The chart above, included in “Illumina Now and Then” on February 10th 2016, was everything an Elliott Wave analyst needed to form a bullish opinion on Illumina stock. It allowed us to recognize a complete 5-3 wave cycle, formed by a five-wave impulse with an ending diagonal in wave 5 and a simple A-B-C correction. According to the theory, once the negative phase of the cycle was over, the larger trend was supposed to resume in the direction of the impulsive sequence. So, while ILMN was searching for a support to bounce up from, we thought “the upcoming rally should be powerful enough to exceed the top at $242.” Nearly two years later, here is how the weekly price chart of Illumina stock looks like today.

illumina stock elliott wave analysis

Once again, patience was required as we could not pick the exact bottom. The stock remained indecisive until December 7th, 2016, when it finally found a bottom at $119.37. However, the count did not change much and all Illumina shareholders had to do was stay calm and wait. On January 9th, 2018, their patience was generously rewarded after the price exceeded the previous all-time high of $242 and climbed to $245.74 on the back of strong Q4 2017 sales expectations.

But instead of relying on the news, which is always very good at the top and very bad near the bottom, we would continue to look at the charts for guidance. In order to find out where does the recent strength fit into the bigger picture, we need to take a look at Illumina’s monthly logarithmic chart below.

illumina stock weekly elliott wave analysis

Logarithmic scale allows us to take a look at he wave structure of Illumina’s entire rally since March 2003, when its phenomenal advance began from $0.86 in split-adjusted prices. As visible, it appears to be an almost complete five-wave impulse. The A-B-C decline in 2016 is labeled as wave (4), which means the spectacular surge in 2017 should be wave (5). Illumina stock’s momentum is strong right now, so chances are good higher levels would be reached in the short-term. Even $300 a share cannot be ruled out at this point.

On the other hand, once wave (5) ends, a major three-wave retracement should follow. Just like a three-wave slump in wave (4) followed a five-wave rally in wave (3), a similar pullback seems to be around the corner for ILMN. Except bigger, because this time it would be retracing Illumina’s entire 15-year uptrend since 2003.



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

You may also like:

WPP Stock Bulls Ready to Fight Back

On July 10, 2017, WPP stock was trading above $101 a share on the New York Stock Exchange, down from its all-time high of $123.33 reached in May, 2015. Despite being down 17.9% already, the Elliott Wave Principle suggested the stock is likely to “lose 30% from current levels”, so we wrote an article to…

Read More »

Canadian National Railway Afraid of NAFTA Breakup?

President Donald Trump has repeatedly criticized the North American Free Trade Agreement between Mexico, the United States and Canada. The White House recently announced that the deal would need to be renegotiated to include better terms for the U.S. What that means exactly remains to be seen, hopefully within the next two weeks, but given…

Read More »

McDonalds Stock to Conquer 180 a Share

Despite declining revenues in the last several years, McDonalds’ profits are still on the rise. The company’s stock was also climbing until late-January 2018, when it reached an all-time high of $178.68. But instead of going for the $180 mark, the bulls could not maintain the positive momentum. A little over a month later, MCD…

Read More »

Foot Locker’s Death Greatly Exaggerated

In about six short months between May and November 2017, Foot Locker lost over 63% of its market capitalization. The retail crisis did not spare FL stock, which crashed from $77.71 on May 10th to $28.42 by November 8th last year, following misses in earnings and revenue in the first two quarters of fiscal 2018.…

Read More »

Amgen Stock in Trouble, Despite Strong Results

Amgen Inc. (NASDAQ:AMGN) reported its full year 2017 results on February 1st. On a non-GAAP basis, the California-based biotech giant earned $12.58 per share, an 8% increase from 2016. But instead of celebrating another year of strong business performance, investors punished Amgen stock, which fell from an all-time high of $201.22 to $168.45 between January…

Read More »

Buckle Stock Looks Bullish Ahead of Earnings

2017 was drawing to a close when we wrote an article about this relatively unknown apparel retailer on December 28th. The Buckle stock (NYSE:BKE) was trading near $24.50 after a four-month rally from as low as $13.60. But instead of falling in love with the recovery and joining the bulls, we decided to listen to…

Read More »

Interpublic, Omnicom to Make Hedge Funds Happy

Facebook and Google are disrupting the advertising business in a way most companies in the industry never thought possible. To make things worse, large consumer companies such as Procter & Gamble and Kraft Heinz have reduced their marketing spending. As a result, traditional advertising companies face slowing revenue growth and uncertain future. Just what hedge…

Read More »

More analyses